Abrogation of etoposide-mediated cytotoxicity by cycloheximide
- 1 March 1988
- journal article
- research article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 37 (6), 1117-1122
- https://doi.org/10.1016/0006-2952(88)90519-9
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Topoisomerase-specific drug sensitivity in relation to cell cycle progression.Molecular and Cellular Biology, 1987
- DNA TOPOISOMERASESAnnual Review of Biochemistry, 1985
- A type-II DNA topoisomerase and a catenating protein from the transplantable VX2 carcinomaEuropean Journal of Biochemistry, 1985
- Inhibition of the DNA catenation activity of type II topoisomerase by VP16-213 and VM26Biochemical and Biophysical Research Communications, 1984
- Comparison of cytotoxicity and DNA breakage activity of congeners of podophyllotoxin including VP16-213 and VM26: a quantitative structure-activity relationshipBiochemistry, 1984
- A method for staining 3T3 cell nuclei with propidium iodide in hypotonic solutionCytometry, 1983
- Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino)methanesulfon-m-anisidide and adriamycinBiochemistry, 1981
- DNA double-strand breaks in mammalian cells after exposure to intercalating agentsBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1981
- Relationship between cytotoxicity and dna strand break-age produced by adriamycin and other intercalating agentsInternational Journal of Radiation Oncology*Biology*Physics, 1979
- The incorporation of 3H-cytosine arabinoside and its effect on murine leukemic cells (L5178Y)Biochemical Pharmacology, 1968